Scoring what matters in Canine Chronic Enteropathy
/ Veterinarian - Back to overview
Canine chronic inflammatory enteropathy (CIE) is characterized by <b>persistent or recurrent gastrointestinal signs lasting ≥ 3 weeks<b>, in which extraintestinal, metabolic, endocrine, infectious and obstructive causes have been excluded as cause.
It remains a diagnosis of exclusion:
| RULE OUT | EXAMPLES |
|---|---|
| Endoparasites | Giardia duodenalis, whipworms, hookworms, roundworms |
| Foreign bodies | |
| Infectious diseases | Bacterial, protozoal or fungal diseases |
| Nephropathies | CKD, protein-losing nephropathy |
| Endocrine disorders | Hypoadrenocorticism, Addison's disease |
| Hepatopathies | Chronic hepatitis, cholangitis |
| Pancreatic disorders | Acute or chronic pancreatitis |
| Neoplasms | Lymphoma, adenocarcinoma |
| Mechanical disease | Intussusception, strictures |
Beyond gut feeling: Measuring real progress in Canine CIE
The Canine Chronic Enteropathy Clinical Activity Index (CCECAI) is one of the most widely used clinical scoring systems for assessing disease severity and monitoring treatment response in dogs with chronic inflammatory enteropathy (CIE).
It combines both owner-observed and veterinarian-assessed parameters, including appetite, activity, vomiting, stool consistency, stool frequency, weight loss, albumin concentration, ascites/oedema, and pruritus, into a single objective score. High CCECAI scores are associated with a less favorable prognosis [Allensbach K 2007].
For the general practitioner, the CCECAI provides a practical and standardized method to quantify disease severity, track changes over time, and evaluate treatment efficacy. Repeated scoring can also support clinical decision-making.
Turning daily observations into shared clinical insights
Importantly, the score also facilitates communication with dog owners. Because many CCECAI variables are based on daily observations at home, owners actively contribute to disease monitoring. This encourages treatment compliance, helps visualize improvements objectively, and promotes a shared understanding of the patient's clinical progress and quality of life.
Clinical Assessment with the CCECAI-Score
| Clinical variable | 0 | 1 | 2 | 3 |
|---|---|---|---|---|
| Attitude/ activity | Normal | Slightly decreased | Moderately decreased | Severely decreased |
| Appetite | Normal | Slightly decreased | Moderately decreased | Severely decreased |
| Vomiting | No vomiting | 1x per week | 2-3x per week | > 3x per week |
| Stool con-sistency | Normal | Slightly soft feces | Very soft feces | Watery diarrhea |
| Stool frequency | Normal | 2-3 per day of fecal blood, mucus or both | 4-5x per day | > 5x per day |
| Weight loss | None | < 5% loss | 5% - 10% loss | > 10% loss |
| Ascites & peripheral edema | None | Mild | Moderate | Severe |
| Pruritus | None | Occasional itching episodes | Regular itching episodes, stop when dog is asleep | Dog regularly wakes up because of itching |
| Serum Albumin | ≥ 2 g/dl | 1.5 – 1.9 g/dl | 1.2 – 1.4 g/dl | < 1.2 g/dl |
Disease severity classification of CIE in dogs
The sum of the nine individual CCECAI domains provides an overall measure of disease severity. The magnitude of the cumulative numerical score is proportional to the degree of inflammatory activity.
| Score | Disease Severity |
|---|---|
| 0 - 3 | Insignificant |
| 4 – 5 | Mild |
| 6 – 8 | Moderate |
| 9 - 11 | Marked |
| ≥ 12 | Severe |
A cornerstone of diagnosis and 1st -line management in Canine CIE
According to current guidelines, a strict dietary trial should be performed early in the diagnostic process. Canine CIE is primarily classified according to treatment response, not histopathologic subtype.
A therapeutic diet (i.e., highly digestible, limited-ingredient novel protein, hydrolyzed protein, elemental protein, fiber-enriched, low-to ultra-low-fat, home-prepared) should be performed for at least 2 weeks. Exclusive feeding is essential. At least 3 trials with different diets should be considered, if possible.
The major diagnostic challenge is identifying dogs that are likely to respond to diet alone and recognizing those requiring advanced diagnostics such as endoscopy and biopsy as well as a different treatment approach.
Mag. Ingrid Sattler
Sources:
Allenspach K, Wieland B, Gröne A, Gaschen F. Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. J Vet Intern Med. 2007 Jul-Aug;21(4):700-8.
Heilmann RM, Jergens AE, Kathrani A, Allenspach K, Salavati Schmitz S, Priestnall SL, Dandrieux JRS, O'Connor AM. ACVIM-endorsed statement: consensus statement and systematic review on guidelines for the diagnosis and treatment of chronic inflammatory enteropathy in dogs. J Vet Intern Med. 2026 Jan 21;40(1):aalaf017.